Acme Generics Private Limited Mycophenolate Export Data — India (DGFT 2022–2026)

Name: Acme Generics Private Limited Mycophenolate Export Records India — #12 Exporter, 14 Shipments, $612.4K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Mycophenolate

India Pharmaceutical Trade Intelligence

$334.4M167 Suppliers100 CountriesHS 30049099

ExportsIndia → UNITED STATES76.6%India → AUSTRALIA6.1%

ImportsGERMANY → India$999.6M ITALY → India$223.6M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: EVERSANA LIFE

Acme Generics Private Limited — Mycophenolate Exporter #12 | $612.4K Trade Value | TransData Nexus | TransData Nexus

Acme Generics Private Limited — Mycophenolate Exporter Profile

Indian Pharmaceutical Exporter · #12 for Mycophenolate · $612.4K export value · DGFT Verified

Acme Generics Private Limited is the #12 Indian exporter of Mycophenolate with $612.4K in export value and 14 verified shipments. Acme Generics Private Limited holds a 0.2% market share in Mycophenolate exports across 1 countries. The company exports 6 pharmaceutical products worth $7.1M across 5 therapeutic categories.

Acme Generics Private Limited — Mycophenolate Export Profile: Buyers & Destinations

Acme Generics Private Limited Mycophenolate export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Mycophenolate?

Country	Value	Shipments	Share
UNITED STATES	$40.2M	804	51.0%
UNITED KINGDOM	$10.9M	218	13.8%
AUSTRALIA	$6.3M	127	8.1%
ITALY	$4.4M	122

Who Are the Top Buyers of Mycophenolate from India?

Buyer	Country	Value	Orders
ASCEND LABORATORIES,LLC	UNITED STATES	$6.5M	131
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$4.9M	98
STRIDES PHARMA INC	UNITED STATES	$3.6M	73
SANDOZ INC. C/O EXEL, INC.	UNITED STATES	$3.6M	72
STRIDES PHARMA INC,	UNITED STATES	$3.1M	63
ASCEND LABORATORIES LLC	UNITED STATES	$2.6M	52
TILLOMED LABORATORIES LTD	UNITED KINGDOM	$2.5M	50
SANDOZ INC C O EXEL INC	UNITED STATES	$1.9M	38
AVET PHARMACCEUTICALS INC.,	UNITED STATES	$1.4M	29
APOTEX PTY LTD	AUSTRALIA	$500.0K	10

India's Mycophenolate is purchased by 512 buyers worldwide. The top buyer is ASCEND LABORATORIES,LLC (UNITED STATES), followed by EVERSANA LIFE SCIENCES SERVICES,LLC and STRIDES PHARMA INC.

How Does Acme Generics Private Limited Compare to Nearest Mycophenolate Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
7	PANACEA BIOTEC PHARMA LIMITED	$1.8M	35	9	$50.0K
9	INTAS PHARMACEUTICALS LTD	$700.0K	14	6	$50.0K
12	ACME GENERICS PRIVATE LIMITED ★	$612.4K	14	1	$43.7K
13	LA RENON HEALTHCARE PRIVATE LIMITED	$604.5K	21	4	$28.8K
14	EMCURE PHARMACEUTICALS LTD	$476.6K	10	3	$47.7K

Acme Generics Private Limited ranks #12 among 167 Indian Mycophenolate exporters. Average shipment value of $43.7K compared to the market average of $520.1K. The closest competitors by value are PANACEA BIOTEC PHARMA LIMITED and INTAS PHARMACEUTICALS LTD.

Which Indian Ports Ship Mycophenolate Exports?

Port	Shipments	% Share
SAHAR AIR	464	18.3%
NHAVA SHEVA SEA (INNSA1)	308	12.2%
SAHAR AIR CARGO ACC (INBOM4)	229	9.1%
JNPT/ NHAVA SHEVA SEA	135	5.3%
DELHI AIR	115	4.5%
AHEMDABAD AIR ACC (INAMD4)	108	4.3%
MUNDRA SEA	97	3.8%
BANGALORE ICD	97	3.8%

Geopolitical & Trade Policy Impact on Acme Generics Private Limited's Mycophenolate Exports

Acme Generics' export operations are currently navigating a complex geopolitical landscape. The recent Israel-Iran tensions have escalated security risks in the Red Sea and Strait of Hormuz, leading to increased shipping costs and extended transit times for Indian exporters. Major carriers have rerouted vessels around the Cape of Good Hope, adding 10–20 days to shipments and raising freight rates by 40–50% on key India–Europe routes. (livemint.com)

Conversely, the U.S. pharmaceutical sector's reshoring initiatives, aimed at reducing dependency on Chinese APIs, present opportunities for Indian manufacturers like Acme. With the U.S. increasing its domestic generic production capacity, Indian firms are exploring partnerships and establishing production facilities stateside, potentially reducing reliance on Chinese imports by 20–30%. (odrindia.in)

Furthermore, the India–European Union Free Trade Agreement, concluded in January 2026, is set to eliminate tariffs on pharmaceuticals, enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to the EU, providing a competitive edge to companies like Acme Generics. (en.wikipedia.org)

Acme Generics Private Limited — Regulatory Compliance & Quality Standards

Acme Generics has demonstrated a strong commitment to regulatory compliance, with its facilities audited and approved by international agencies, including the USFDA, UK-MHRA, EU-GMP, Health Canada, TGA Australia, ANVISA, INVIMA, and WHO Geneva. (acmegenerics.in) This adherence to stringent quality standards enhances the company's credibility and facilitates access to regulated markets.

The evolving global regulatory environment, characterized by initiatives like the EU's Critical Medicines Act, emphasizes the need for diversified and resilient supply chains. Acme's proactive approach to compliance positions it well to navigate these changes and maintain its competitive standing in the international pharmaceutical market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Mycophenolate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Acme Generics Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 100+ countries, 512+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Mycophenolate

Mycophenolate

Acme Generics Private Limited — Mycophenolate Exporter Profile

Acme Generics Private Limited — Mycophenolate Export Profile: Buyers & Destinations

Where Does India Export Mycophenolate?

Who Are the Top Buyers of Mycophenolate from India?

What Is India's Total Mycophenolate Export Value and How Much Does Acme Generics Private Limited Contribute?

What Is the Average Shipment Value for Acme Generics Private Limited's Mycophenolate Exports?

How Does Acme Generics Private Limited Compare to Other Indian Mycophenolate Exporters?

Regulatory Requirements: Exporting Mycophenolate to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Acme Generics Private Limited Compare to Nearest Mycophenolate Exporters?

Which Indian Ports Ship Mycophenolate Exports?

Geopolitical & Trade Policy Impact on Acme Generics Private Limited's Mycophenolate Exports

Acme Generics Private Limited — Regulatory Compliance & Quality Standards

About Acme Generics Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Mycophenolate Export Data from Acme Generics Private Limited

Mycophenolate Stats

Company Overview

Top Products by Acme Generics Private Limited

Related Analysis

Need Detailed Export Data?

Data Source